NVO May 2024 100.000 call
| Previous close | 27.20 |
| Open | 27.20 |
| Bid | 24.80 |
| Ask | 28.20 |
| Strike | 100.00 |
| Expiry date | 2024-05-03 |
| Day's range | 27.20 - 27.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
- Yahoo Finance Video
Apple earnings on tap, investors digest Fed decision: Yahoo Finance
It's a busy day on Wall Street with investors bracing for earnings from numerous top names, including Apple (AAPL), Coinbase (COIN), Block (SQ), DraftKings (DKNG), Peloton (PTON), Novo Nordisk (NVO), and Moderna (MRNA). Apple is in focus, with investors bracing for key sales numbers out of China. Traders are still digesting the Federal Reserve's decision to leave interest rates unchanged at a 23-year high of 5.25%-5.50%. During his press conference yesterday, Chair Jerome Powell hinted that the central bank's next move will unlikely be a rate hike. Yahoo Finance trending tickers include Carvana (CVNA), NIO (NIO), and Qualcomm (QCOM). Key guests include:9 a.m. ET - Gabriela Santos, J.P. Morgan Asset Management Chief Global Strategist for the Americas9:15 a.m. ET - Lars Fruergaard Jørgensen, Novo Nordisk CEO10 a.m. ET - Deepak Puri, Deutsche Bank CIO Americas10:15 a.m. ET - Akash Palkhiwala, Qualcomm CFO10:30 a.m. ET - John Rogers, Ariel Investments Co-CEO10:40 a.m. ET - Stéphane Bancel, Moderna CEO10:50 a.m. ET - Stephen Yalof, Tanger CEO11:15 a.m. ET - Michael Skipworth, Wingstop CEO
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
Investor's Business DailyNovo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Novo Nordisk stock dipped Thursday after sales of weight-loss drug, Wegovy, nearly doubled, but missed even more bullish expectations.
